From October 1, 2022 to December 29, 2022, the company has repurchased 120,000 shares, representing 2% for KRW 3,418.04 million. With this, the company has completed the repurchase of 120,000 shares, representing 2% for KRW 3,418.04 million under the buyback announced on September 28, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28,800 KRW | +0.88% | +0.70% | +3.78% |
2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.78% | 125M | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- A023910 Stock
- News Daihan Pharmaceutical Co.,Ltd.
- Tranche Update on Daihan Pharmaceutical Co.,Ltd.'s Equity Buyback Plan announced on September 28, 2022.